Neoduplamox Bambini (Amoxicillin, Clavulanic Acid)

Amoxicillin, the active ingredient in Neoduplamox Bambini, is a Penicillin beta‑lactam antibiotic presented as a pediatric oral suspension for oral use. It treats a range of bacterial infections commonly seen in children, including ear, sinus, throat and respiratory tract infections.

GNH USA supplies Neoduplamox Bambini as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neoduplamox Bambini, a broad‑spectrum penicillin beta‑lactam, is used to treat bacterial infections of the upper and lower respiratory tract, urinary system and skin. - Acute otitis media: clears bacterial infection of the middle ear in children. - Sinusitis: reduces sinus inflammation caused by susceptible bacteria. - Pharyngitis / tonsillitis: eradicates streptococcal throat infections. - Community‑acquired pneumonia: combats bacterial pneumonia in pediatric patients. - Urinary tract infections: eliminates common uropathogens. - Skin and soft tissue infections: treats cellulitis and wound infections caused by susceptible organisms.

Adverse reactions may occur with any antibiotic. Most are mild and self‑limiting, but serious events require immediate medical attention.

Common Side Effects: - Diarrhoea: loose stools occurring during therapy. - Nausea: feeling of queasiness or upset stomach. - Vomiting: expulsion of stomach contents. - Rash: mild skin redness or itching. - Abdominal pain: discomfort or cramps in the stomach area. - Taste disturbance: altered sense of taste.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with breathing difficulty. - Stevens‑Johnson syndrome: rare skin blistering condition. - Clostridioides difficile‑associated diarrhoea: severe colitis after antibiotic use. - Hepatic enzyme elevation: abnormal liver function tests. - Neutropenia: low white‑blood‑cell count increasing infection risk. - Seizures: rare neurologic events, especially in high doses or renal impairment.

Before prescribing Neoduplamox Bambini, clinicians should evaluate patient‑specific factors and follow safe handling guidelines. - Allergy assessment: avoid in patients with known hypersensitivity to penicillins or clavulanic acid. - Renal function: dose adjustment may be required in severe renal impairment. - Hepatic function: monitor liver enzymes in patients with liver disease. - Use in pregnancy: prescribe only if benefits outweigh potential risks. - Drug interactions: review concomitant medications for possible interactions. - Store at ambient temperature: keep below 25 °C, retain in the original pack, and protect from moisture.

Neoduplamox Bambini can affect, or be affected by, several co‑administered medicines. Monitoring and dose adjustments may be necessary.

Major Interactions (Avoid): - Probenecid: increases amoxicillin plasma levels, raising toxicity risk. - Methotrexate: may amplify methotrexate toxicity. - Oral contraceptives: reduced efficacy, increasing risk of unintended pregnancy.

Moderate Interactions (Monitor Closely): - Warfarin: potentiates anticoagulant effect; monitor INR. - Allopurinol: higher incidence of rash; observe skin reactions. - Ciprofloxacin: may diminish antibacterial activity; assess clinical response.